InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47
United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Markus Warmuth
1 Jun 2026
President & CEO
Sold on a plan
468
$19.73
$9.23K
Markus Warmuth
1 Jun 2026
President & CEO
Sold on a plan
4,998
$19.41
$97.02K
Markus Warmuth
1 May 2026
President & CEO
Sold on a plan
5,467
$18.92
$103.45K
Markus Warmuth
2 Mar 2026
President & CEO
Sold on a plan
5,466
$17.92
$97.97K
Markus Warmuth
7 Jan 2026
President & CEO
Sold on a plan
309
$24.57
$7.59K
Markus Warmuth
7 Jan 2026
President & CEO
Sold on a plan
1,450
$23.88
$34.62K
Markus Warmuth
7 Jan 2026
President & CEO
Sold on a plan
3,707
$23.24
$86.16K
Show all 37 transactions →

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 18
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 1,377,460
History held since 25 Jun 2021